Bengaluru Neuro Center Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -64.85%
- Profit Growth 47.65%
- Ebitda 45.45%
- Net Worth 32.42%
- Total Assets 42.40%
About Bengaluru Neuro Center
Bengaluru Neuro Center Private Limited (BNCPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2012 and has a history of 12 years and ten months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Renukaradhya Umashankar and Davanagere Savitha serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85110KA2012PTC063116
-
Company No.
063116
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Mar 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Bengaluru Neuro Center?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Renukaradhya Umashankar
|
Director | 20-Mar-2012 | Current |
|
Davanagere Savitha
|
Director | 20-Mar-2012 | Current |
Financial Performance of Bengaluru Neuro Center.
Bengaluru Neuro Center Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 64.85% decrease. The company also saw a substantial improvement in profitability, with a 47.65% increase in profit. The company's net worth Soared by an impressive increase of 32.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bengaluru Neuro Center?
In 2019, Bengaluru Neuro Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Snig Pharma Private LimitedRenukaradhya Umashankar and Davanagere Savitha are mutual person
-
Pan-Asia Hospitals Private LimitedRenukaradhya Umashankar is a mutual person
-
Siddaganga Diagnostic Centre Private LimitedRenukaradhya Umashankar is a mutual person
-
Saakalya Hospitals Private Limited
Renukaradhya Umashankar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bengaluru Neuro Center?
Unlock and access historical data on people associated with Bengaluru Neuro Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bengaluru Neuro Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bengaluru Neuro Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.